ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Return
7.83%
This Quarter Return
+22.93%
1 Year Return
-7.83%
3 Year Return
+43.87%
5 Year Return
+57.06%
10 Year Return
–
AUM
$331M
AUM Growth
+$35.3M
(+12%)
Cap. Flow
-$26.1M
Cap. Flow
% of AUM
-7.89%
Top 10 Holdings %
Top 10 Hldgs %
25.23%
Holding
739
New
58
Increased
120
Reduced
241
Closed
68
Top Buys
| 1 |
iShares MSCI China ETF
MCHI
|
$11.3M |
| 2 |
iShares MSCI South Africa ETF
EZA
|
$8.2M |
| 3 |
iShares MSCI Malaysia ETF
EWM
|
$6.7M |
| 4 |
UBS Group
UBS
|
$6.6M |
| 5 |
Linde
LIN
|
$6.28M |
Top Sells
| 1 |
RSX
VanEck Russia ETF
RSX
|
$11.1M |
| 2 |
VanEck Gold Miners ETF
GDX
|
$10.9M |
| 3 |
iShares MSCI Turkey ETF
TUR
|
$10.5M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
$8.84M |
| 5 |
Snap
SNAP
|
$3.88M |
Sector Composition
| 1 | Technology | 15.15% |
| 2 | Financials | 12.78% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 9.26% |
| 5 | Communication Services | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Vanguard Energy ETF
VDE
$7.2B
| $101K | 0.03% |
2,000
| – | – |
|
277
Merit Medical Systems
MMSI
$5.51B
| $100K | 0.03% |
2,196
-308
| -12% | -$14.1K |
|
278
Regenxbio
RGNX
$490M
| $100K | 0.03% |
2,714
+2,700
| +19,286% | +$99.4K |
|
279
Masimo
MASI
$8B
| $98K | 0.03% |
430
-97
| -18% | -$22.1K |
|
280
Zymeworks
ZYME
$1.14B
| $97.4K | 0.03% |
+2,700
| New | +$97.4K |
|
281
Rapid7
RPD
$1.32B
| $96.3K | 0.03% |
1,887
-3,626
| -66% | -$185K |
|
282
HCA Healthcare
HCA
$98.5B
| $96.2K | 0.03% |
991
-3,494
| -78% | -$339K |
|
283
Service Corp International
SCI
$10.9B
| $95.7K | 0.03% |
+2,462
| New | +$95.7K |
|
284
Republic Services
RSG
$71.7B
| $94.9K | 0.03% |
1,157
-310
| -21% | -$25.4K |
|
285
Tilray
TLRY
$1.31B
| $93.1K | 0.02% |
13,071
+1,911
| +17% | +$13.6K |
|
|
TCDA
286
DELISTED
Tricida, Inc. Common Stock
TCDA
| $92.9K | 0.02% |
3,380
| – | – |
|
|
CCXI
287
DELISTED
ChemoCentryx, Inc.
CCXI
| $92.7K | 0.02% |
1,612
-517
| -24% | -$29.7K |
|
288
United Parcel Service
UPS
$72.1B
| $92.5K | 0.02% |
832
-1,954
| -70% | -$217K |
|
289
Phathom Pharmaceuticals
PHAT
$875M
| $91.4K | 0.02% |
2,777
-325
| -10% | -$10.7K |
|
290
Philip Morris
PM
$251B
| $90.9K | 0.02% |
1,298
-20,348
| -94% | -$1.43M |
|
|
BCEL
291
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $90.9K | 0.02% |
4,270
| – | – |
|
292
BioMarin Pharmaceuticals
BMRN
$11.1B
| $89.8K | 0.02% |
728
| – | – |
|
293
Freeport-McMoran
FCX
$66.5B
| $89.7K | 0.02% |
7,756
-8,081
| -51% | -$93.5K |
|
294
Under Armour
UAA
$2.2B
| $86.9K | 0.02% |
8,922
-63,734
| -88% | -$621K |
|
|
ATRS
295
DELISTED
Antares Pharma, Inc.
ATRS
| $86.6K | 0.02% |
31,494
-317
| -1% | -$872 |
|
296
PTC Therapeutics
PTCT
$4.55B
| $85.8K | 0.02% |
1,691
| – | – |
|
297
Financial Select Sector SPDR Fund
XLF
$53.2B
| $85.2K | 0.02% |
3,682
-1,303
| -26% | -$30.2K |
|
298
ADMA Biologics
ADMA
$4.03B
| $83.7K | 0.02% |
+28,553
| New | +$83.7K |
|
299
Valero Energy
VLO
$48.7B
| $80K | 0.02% |
1,360
-38,231
| -97% | -$2.25M |
|
300
Autodesk
ADSK
$69.5B
| $78.2K | 0.02% |
327
-79
| -19% | -$18.9K |
|